The pharmaceutical industry is grappling with drug shortages, and it's crucial to address this issue through strategies, technologies, and regulations.

Manufacturers need to embrace cutting-edge technologies, such as digital twins for predictive maintenance, AI for precise supply chain management, and VR/AR for training and efficiency. Regulations play a dual role, potentially hindering innovation due to complexity, but also encouraging it through adaptive pathways.

Dialogue about AI and advanced manufacturing is ongoing, with the FDA seeking feedback on AI in drug manufacturing. Challenges include explaining AI decisions, ensuring accountability, and addressing biases. The FDA's role in regulating AI is vital for balancing innovation, ethics, and safety in the life sciences sector.

Overall, collaboration between manufacturers, technology, and regulations could lead to improved drug manufacturing and supply stability despite persistent shortages.